UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1151-1157

2009

Volltextzugriff (PDF)

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2008-09, Vol.135 (3), p.821-829

2008

Volltextzugriff (PDF)

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

Gastroenterology (New York, N.Y. 1943), 2008-02, Vol.134 (2), p.416-423

2008

Volltextzugriff (PDF)

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C

Liver international, 2012-04, Vol.32 (4), p.612-621

2012

Volltextzugriff (PDF)

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.728-735

2006

Volltextzugriff (PDF)

Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin

Hepatology (Baltimore, Md.), 2010-04, Vol.51 (4), p.1122-1126

2010

Volltextzugriff (PDF)

Eighth major clade for hepatitis delta virus

Emerging infectious diseases, 2006-09, Vol.12 (9), p.1447-1450

2006

Volltextzugriff (PDF)

In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model

Gut, 2014-09, Vol.63 (9), p.1490-1500

2014

Volltextzugriff (PDF)

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2018-12, Vol.155 (6), p.1816-1827.e9

2018

Volltextzugriff (PDF)

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody

Liver international, 2009-04, Vol.29 (4), p.511-517

2009

Volltextzugriff (PDF)

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

Journal of hepatology, 2010-05, Vol.52 (5), p.652-657

2010

Volltextzugriff (PDF)

Patient adherence issues in the treatment of hepatitis C

Patient preference and adherence, 2014-01, Vol.8 (default), p.763-773

2014

Volltextzugriff (PDF)

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Journal of hepatology, 2012-03, Vol.56 (3), p.527-532

2012

Volltextzugriff (PDF)

Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study

Alcohol and alcoholism (Oxford), 2023-03, Vol.58 (2), p.117-124

2023

Volltextzugriff (PDF)

Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin

Gastroenterology (New York, N.Y. 1943), 2006-06, Vol.130 (7), p.2189-2197

2006

Volltextzugriff (PDF)

Outcomes of upper gastrointestinal bleeding are similar between direct oral anticoagulants and vitamin K antagonists

Alimentary pharmacology & therapeutics, 2021-03, Vol.53 (6), p.688-695

2021

Volltextzugriff (PDF)

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Journal of clinical virology, 2013-10, Vol.58 (2), p.401-407

2013

Volltextzugriff (PDF)

High coffee consumption is not associated with less liver fibrosis in non-alcoholic steato-hepatitis: Results of the COCANASH study

Nutrition clinique et métabolisme, 2024-03, Vol.38 (1), p.22-26

2024

Volltextzugriff (PDF)

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

Antiviral therapy, 2009-11, Vol.14 (8), p.1183-1188

2009

Volltextzugriff (PDF)

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy

Pathogens (Basel), 2023-02, Vol.12 (2), p.332

2023

Volltextzugriff (PDF)

Prospective evaluation of the management of hepatocellular carcinoma in the elderly

Digestive and liver disease, 2011-12, Vol.43 (12), p.1001-1005

2011

Volltextzugriff (PDF)

Prognostic factors associated with upper gastrointestinal bleeding based on the French multicenter SANGHRIA trial

Endoscopy International Open, 2021-10, Vol.9 (10), p.E1504-E1511

2021

Volltextzugriff (PDF)

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

Antiviral therapy, 2009-01, Vol.14 (4), p.501-511

2009

Volltextzugriff (PDF)

Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)

La Presse médicale (1983), 2019-03, Vol.48 (3), p.e101-e110

2019

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(56)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin

Eighth major clade for hepatitis delta virus

In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

Patient adherence issues in the treatment of hepatitis C

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study

Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin

Outcomes of upper gastrointestinal bleeding are similar between direct oral anticoagulants and vitamin K antagonists

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

High coffee consumption is not associated with less liver fibrosis in non-alcoholic steato-hepatitis: Results of the COCANASH study

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy

Prospective evaluation of the management of hepatocellular carcinoma in the elderly

Prognostic factors associated with upper gastrointestinal bleeding based on the French multicenter SANGHRIA trial

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)

Suchergebnisse filtern